| Catalog No. |
Size |
Price |
Figures |
|---|
Z00024-1 mg
| 1 mg | $ 420.00 |
References:
- Kusov YY, Gauss-Muller V. In vitro RNA binding of the hepatitis A virus proteinase 3C (HAV 3Cpro) to secondary structure elements within the 5' terminus of the HAV genome. RNA. Mar 1997;3(3):291-302.
- Gosert R, Dollenmaier G, Weitz M. Identification of active-site residues in protease 3C of hepatitis A virus by site-directed mutagenesis. J Virol. Apr 1997;71(4):3062-8.
|
|---|
| Full Name | | Hepatitis A Virus (HAV) P3C |
|
| Abbreviated Name-1 | Hepatitis P3C; HAV P3C |
|---|
| Description | Hepatitis A Virus (HAV) P3C ia an E. coli-derived recombinant. The protein Hepatitis A Virus (HAV) P3C contains the P3C immunodominant region. |
|---|
| Source | E. coli |
|---|
| Purity | Protein is >90% pure as determined by 10% PAGE (coomassie staining). |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
|---|
| Concentration | 1 mg/ml in 10 mM CBB, pH9.6, 0.1% SDS, 50% glycerol. |
|---|
| Stability | Five years frozen. One month in solution at room temperature. |
|---|
| Specificity | Immunoreactive with sera of HAV-infected individuals. |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of HAV with minimal specificity problems. |
|---|
